Target intelligence / Profile preview

VOPP1 divergent transcript (VOPP1-DT)

Target
VOPP1-DT
Molecular classification
Other (long non-coding RNA; lncRNA)
01

Overview

VOPP1 divergent transcript (VOPP1-DT) refers to a long non-coding RNA (lncRNA) transcribed from the region adjacent to, and in the opposite direction from, the VOPP1 protein-coding gene. Divergent transcription is a common phenomenon at promoters and enhancers in mammalian genomes, producing non-coding RNAs whose abundance and function are often poorly understood. There is no evidence that VOPP1-DT encodes a protein or functions as a receptor, enzyme, or other conventional drug target. It is best classified as a genomic feature that reflects the diversity of non-coding RNA transcription but has not been established as a specific therapeutic target or biomarker[1][3][5]. Summary: - VOPP1-DT is not a protein, receptor, or conventional drug target. - It refers generically to a divergent lncRNA transcript at the VOPP1 locus. - Its functions and disease relevance are undefined, with no supporting evidence for biomarker or drug-target roles. - The name is correct as a non-coding RNA locus, but it is not a target in the pharmaceutical or therapeutic sense[1][3][5].

02

Mechanism of action

None known

03

Biological functions

Other (not clearly established; divergent transcripts may influence local chromatin structure or transcriptional regulation, but specific roles for VOPP1-DT are not defined)
04

Disease associations

Other (no direct disease associations established for VOPP1-DT; however, the parental VOPP1 gene is linked to glioblastoma)

Beyond the preview

Go deeper on VOPP1 divergent transcript (VOPP1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VOPP1 divergent transcript (VOPP1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call